Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Issy-Les-Moulineaux, France Clinical Trials

A listing of Issy-Les-Moulineaux, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (20) clinical trials

Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis

Patients with neurofibromatosis type 1 have numerous eye problems: glioma of the optic pathways, Lisch nodules, palpebral involvement by plexiform neurofibromas, orbital dysplasia, etc. With the emergence of multimodal imaging in ophthalmology a new ocular involvement has been described: choroidal hyperreflective areas. They are located in the most superficial layers …

Phase N/A

1.48 miles

Learn More »

Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19

The main objective of this study is to evaluate the hospital survival of COVID-19 patients supported by venovenous or venoarterial ECMO in a multicenter registry. The secondary objectives are to describe the characteristics of COVID-19 patients who have received ECMO support, to identify the risk factors associated with hospital mortality, …

Phase N/A

1.48 miles

Learn More »

COVID-19 bLOod Coagulation and Thrombosis

Coronavirus 2 (SARS-CoV2) has been identified as the pathogen responsible for severe acute respiratory syndrome associated with severe inflammatory syndrome and pneumonia (COVID-19). Described at the end of 2019 in China, the pandemic sees the number of patients increasing worldwide, Europe being still in the ascending phase of the epidemic …

Phase N/A

1.85 miles

Learn More »

Place of Intrathecal Analgesia to Improve the Quality of Life of Painful Cancer Patients

The referent algologist informs the patient of the retained offer in the pain multidisciplinary consultation meeting. Following the consultation, the investigator sees the patient to explain the study and to verify all the inclusion and non-inclusion criteria, to give and explain the information note and to be sure of the …

Phase N/A

1.85 miles

Learn More »

Evaluation of an Early Support Programme in Orthophony

Prospective, interventionnal with minimal risks and constraints, multicentric, non-randomized, open study, to measure the impact of an early support programme in speech and language therapy for vulnerable children (PAPEV-ortho), in children born very prematurely or very hypotrophically, on the incidence of language and communication deficits at the corrected age of …

Phase N/A

1.88 miles

Learn More »

Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients

ALBAN study will randomize 614 patients in 30 centers in France, according to a ratio 1:1 in the following arms of treatment: arm A (control arm): BCG only arm B (experimental arm): BCG+ atezoliumab The are two factors of stratifications (center and CIS).

Phase

2.38 miles

Learn More »

Transcranial Ultrasound Therapy of Essential Tremor

Context Essential tremor (ET) is the most common movement disorder, with a prevalence of 1-4% of the general population. ET is characterized by a rapid (6 and 12 Hz) attitude tremor with rhythmic oscillations of agonist and antagonist muscle groups. ET most often affects the upper limbs, the head and …

Phase N/A

3.88 miles

Learn More »

A Phase 1/2 Study of SHP648 an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects

This study will consists of 3 dose cohorts with 2-7 participants in each of the three ascending dose cohorts. Initially 2 participants will be dosed in Cohort 1, followed by dosing of up to 5 additional participants if the cohort is expanded. Participants in cohort 2 and 3 will receive …

Phase

3.89 miles

Learn More »

Observational Cohort of COVID-19 Patients at Raymond-Poincare

COVID-19 is a virus belonging to the coronavirus family, which includes a large number of viruses that can cause a wide variety of diseases in humans. The SARS-CoV-2 virus that caused the current COVID-19 pandemic, although widely described in the literature, still has many grey areas. The main clinical manifestation …

Phase N/A

4.15 miles

Learn More »

Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis

The potential benefits of a lower dose ( 400 mg of hydrocortisone or equivalent per day), and a longer duration at full dose ( three days) of treatment, have been investigated in numerous randomized controlled trials over the past three decades. In the past two years, guidelines for clinical practices …

Phase N/A

4.15 miles

Learn More »